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Docking studyAbstract A novel series of 2-[5-(4-substituted phenyl)furan-2-yl]-4,5-diphenyl-1H-imidazole deriv-
atives (2a–c) were synthesized and characterized using IR, 1H NMR and GC–MS spectra. These
compounds were in vitro screened against several bacterial species as well as Candida albicans,
the common fungi species and found exhibiting moderate to potent activity. Docking of synthesized
compounds against glucosamine-6-phosphate synthase, the target enzyme for the antimicrobial
agents, was achieved to explore and explain the interactions of the discovered hits within the amino
acid residues of the enzyme binding pocket. The docking results enhanced the activity of new deriv-
atives as promising antimicrobial agents.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
According to the World Health Organization (WHO), the anti-
microbial resistance and the limited number of efﬁcacious anti-
microbial drugs represent the main hurdle to the treatment of
infectious diseases worldwide. Thus, the synthesis and discov-
ery of new efﬁcient antimicrobial agents is intensively consid-
ered during the last decade (None, 2012). In recent years,
signiﬁcant attention has been drawn to imidazole derivatives
due to their diversiﬁed therapeutic activities like antibacterial(Kathiravan et al., 2012), antifungal (Hussain et al., 2009),
antiviral (Tonelli et al., 2010), anti-inﬂammatory (Barta
et al., 1998), antitubercular (Shingalapur et al., 2009), antide-
pressant (Wentland et al., 1987) and antitumor (Refaat,
2010). These facts encouraged us to explore the synthesis of
novel imidazole derivatives and illustrate their activities
against some gram positive and gram negative bacteria as well
as Candida albicans, the most common fungi species. To ex-
plain the promising activity of these derivatives, this research
includes the molecular docking of synthesized compounds
within the binding pocket of L-Glutamine: D-fructose-6-phos-
phate amidotransferase, known under the trivial name of glu-
cosamine-6-phosphate synthase (GlcN-6-P) which represents
the effective target in antimicrobial chemotherapy. This en-
zyme catalyzes the ﬁrst step in hexosamine biosynthesis, con-
verting D-fructose 6-phosphate (Fru-6-P) into D-glucosamine
6-phosphate (GlcN-6-P) using glutamine as the ammonia
source and leading to the eventual formation of uridine
S510 I.H.R. Tomi et al.50-diphospho-N-acetyl-D-glucosamine (UDP-GlcNAc), the
important point of metabolic control in the biosynthesis of
amino sugar-containing macromolecules which is necessary
for the cell wall assembly in bacteria and fungi (Bearne and
Blouin, 2000). Autodock 4.2, the effective tool for exploring
the binding afﬁnity of small molecule to enzyme target (Morris
et al., 1998) was used to study the interactions between the
imidazole derivatives and the GlcN-6-P synthase binding site.
2. Experimental part
2.1. Synthesis
All starting materials and solvents were purchased from Al-
drich and Fluka and used without further puriﬁcation. Melting
points were determined on a electro-thermal capillary appara-
tus and are uncorrected; FT-IR measurements were recorded
on a Shimadzu model FTIR-8400S. Mass spectra were re-
corded on a Shimadzu GCMS-QP2010 Ultra apparatus. 1H
NMR spectra were obtained with a Bruker spectrophotometer
model ultra shield at 300 MHz in DMSO-d6 solution with the
TMS as internal standard. Note: in 1H NMR spectra, the
peaks at d 2.5 and 3.35 are for solvent (DMSO-d6) and dis-
solved water in (DMSO-d6), respectively.
2.2. General procedure for the synthesis of 5-(4-substituted
phenyl)furan-2-carboxaldehyde (1a–c)
These compoundswere synthesized according to the procedure de-
scribed in reference (Puterova´ et al., 2004). 4-Substituted aniline
(0.136 mol) was dissolved in a mixture of concentrated HCl
(33.7 mL) and H2O (22.5 mL). The solution was cooled to 0 C
and diazotized at 0–5 Cwith sodium nitrite (9.5 g, 0.138 mol) dis-
solved in H2O (25 mL). The solution was stirred for another
10 min, ﬁltered and then furan-2-carboxaldehyde (15.4 g,
0.16 mol) in H2O (50 mL) was added along with a solution of Cu-
Cl2Æ2H2O (5 g, 0.04 mol) in H2O (25 mL) at a temperature of 10–
15 C. The reaction mixture was slowly warmed up to 40 C and
stirred at this temperature for 4 h. The precipitate was ﬁltered with
suction, washed with water and an aqueous solution of sodium
hydrogen carbonate (5%) and water. The products were dried at
room temperature and recrystallized from ethanol.
2.2.1. 5-(4-Bromophenyl)furan-2-carboxaldehyde 1a
Dark brown powder, yield 59%, mp. 154–156 C; IR (KBr,
cm1): 3111 (aromatic C–H), 2860 (aldehyde C–H), 1680
(C‚O), 1595, 1521 (C‚C). 1H-NMR (300 MHz, DMSO-
d6): d (ppm) 7.32 (1H, d, H furan, j= 3.64 Hz), 7.63 (1H, d,
H furan, j= 3.64 Hz), 7.68 (2H, d, H aromatic,
j= 8.37 Hz), 7.79 (2H, d, H aromatic, j= 8.37 Hz), 9.62 (s,
1H, H aldehyde).NH2X
1- NaNO2, HCl
2- Furan-2-carboxaldehyde, CuCl2 O CHO
X
Compounds 1a-c
Scheme 1 Preparation of im2.2.2. 5-(4-Chlorophenyl) furan-2-carboxaldehyde 1b
Dark brown powder, yield 67%, mp. 130–132 C; IR (KBr,
cm1): 3100 (aromatic C–H), 2856 (aldehyde C–H), 1681
(C‚O), 1600, 1519 (C‚C). 1H-NMR (300 MHz, DMSO-
d6): d (ppm) 7.32 (1H, d, H furan, j= 3.75 Hz), 7.55 (2H, d,
H aromatic, j= 8.63 Hz), 7.65 (1H, d, H furan,
j= 3.75 Hz), 7.87 (2H, d, H aromatic, j= 8.63 Hz), 9.62 (s,
1H, H aldehyde).
2.2.3. 5-(4-Nitrophenyl) furan-2-carboxaldehyde 1c
Dark orange powder, yield 62%, mp. 202–205 C; IR (KBr,
cm1): 3119 (aromatic C–H), 2845 (aldehyde C–H), 1685
(C‚O), 1602, 1519 (C‚C). 1H-NMR (300 MHz, DMSO-d6):
d (ppm) 7.57 (1H, d,H furan, j= 3.75 Hz), 7.70 (1H, d,H furan,
j= 3.75 Hz), 8.12 (2H, d,Haromatic, j= 8.80 Hz), 8.33 (2H, d,
H aromatic, j= 8.80 Hz), 9.67 (s, 1H, H aldehyde).
2.3. General procedure for the synthesis of 2-[5-(4-substituted
phenyl)furan-2-yl]-4,5-diphenyl-1H-imidazole (2a–c)
These compounds were prepared according to the procedure
described in reference (Nagalakshmi, 2008). A mixture of ben-
zil (0.025 mol), ammonium acetate (0.129 mol) and 5-(4-substi-
tuted phenyl)furan-2-carboxaldehyde (0.025 mmol) (1a–c) in
glacial acetic acid (50 mL) was heated under reﬂux for 5–6 h.
After reﬂuxing, the reaction mixture was allowed to stand to
attain room temperature. The precipitated solid was dried in
vacuum and recrystallized from absolute ethanol.
2.3.1. 2-[5-(4-Bromophenyl)furan-2-yl]-4,5-diphenyl-1H-
imidazole 2a
Brown crystals, yield 70%, mp. 268–270 C; IR (KBr, cm1):
3437 (N–H), 3053 (aromatic C–H), 1681 (C‚N), 1599, 1489
(C‚C). 1H-NMR (300 MHz, DMSO-d6): d (ppm) 6.87–8.09
(16H, m, HAr), 13.00 (s, 1H, NH). GCMS (EI) m/z: 442
(M+ H)+ for C25H17BrN2O.
2.3.2. 2-[5-(4-Chlorophenyl)furan-2-yl]-4,5-diphenyl-1H-
imidazole 2b
Brown crystals, yield 70%, mp. 282–284 C; IR (KBr, cm1):
3377, 3306 (N–H), 3055 (aromatic C–H), 1680 (C‚N), 1599,
1489 (C‚C). 1H-NMR (300 MHz, DMSO-d6): d (ppm)
7.09–8.10 (16H, m, HAr), 13.00 (s, 1H, NH). GCMS (EI) m/
z: 397 (M+ H)+ for C25H17ClN2O.
2.3.3. 2-[5-(4-Nitrophenyl)furan-2-yl]-4,5-diphenyl-1H-
imidazole 2c
Reddish brown crystals, yield 72%, mp. 278–280 C; IR (KBr,
cm1): 3373 (N–H), 3061 (aromatic C–H), 1680 (C‚N), 1599,
1518 (C‚C). 1H-NMR (300 MHz, DMSO-d6): d (ppm) 7.15–Ph-CO-CO-Ph, Ammonium acetate
Acetic acid
O
X HN
N
Compounds 2a-c
X= Br, Cl, NO2
idazole derivatives 2a–c.
Figure 1 IR spectrum of imidazole derivatives a – 2a, b – 2b, and c – 2c.
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Figure 2 1H NMR spectrum of imidazole derivatives a – 2a, b –
2b, and c – 2c.
S512 I.H.R. Tomi et al.8.43 (16H, m, HAr), 13.10 (s, 1H, NH). GCMS (EI) m/z: 408
(M+ H)+ for C25H17N3O3.
2.4. Antimicrobial studies
The imidazole derivatives (2a–c) were tested for their antimi-
crobial activity against Escherichia coli, Pseudomonas aerugin-
osa, Klebsiella pneumoniae (gram ve), Staphylococcus aureus,
Streptococcus SPP (gram +ve) as well as C. albicans using the
well diffusion method (Tomi et al., 2010). DMSO was run as a
control and the test was performed at 1 and 10 mg/mL concen-
tration using DMSO solvent. Ampicillin and Fluconazole were
used as standard drugs. Each experiment was made in tripli-
cate and the average reading was taken.
2.5. Docking studies
In this study we used AutoDock 4.2 package software to inves-
tigate the afﬁnity of imidazole derivatives to the binding pock-
et of GlcN-6-P synthase. The pdb ﬁle format of enzyme as
receptor was obtained from the RCSB Protein Data Bank
(PDB code 1MOQ) and used as a rigid molecule. Water mol-
ecules were removed and hydrogen atoms were added to the
protein amino acids. All the docked compounds were drawn
using ChemDraw ultra 7.0 as mol ﬁle and the energies of com-
pounds were minimized then converted into the pdb format
using open Babel 2.3.1 software. During the docking, the grid
dimensions were 60 · 60 · 60 A˚ with points separated by
0.375 A˚. The X, Y and Z coordinates were speciﬁed as 31.0,
17.0 and 2.0, respectively. Lamarckian Genetic Algorithm
was employed as the docking algorithm with 10 runs, 150 pop-
ulation size, 2,500,000 maximum number of energy evaluations
and 27,000 maximum number of generations.
3. Results and discussion
3.1. Synthesis
5-(4-Substituted phenyl)furan-2-carboxaldehyde (1a–c) were
obtained by the reaction of the diazonium salts RPhN2
+Cl
and furan-2-carboxaldehyde in the presence of cuprous chlo-
ride (Meerwein method). Novel 2-[5-(4-substituted phenyl)fur-
an-2-yl]-4,5-diphenyl-1H-imidazole derivatives (2a–c) were
synthesized in excellent yield by the reﬂuxing of aldehyde com-
pounds (1a–c), benzil and ammonium acetate mixture in the
presence of glacial acetic acid as summarized in Scheme 1.
The synthesized derivatives were characterized after recrys-
tallization from an appropriate solvent by recording their IR,
1H NMR and GC–MS spectra. The IR spectrum of compound
1a showed absorption at 3111 cm1 which is due to the aro-
matic C–H stretching, while the C–H stretching frequency of
aldehyde appeared at 2860 cm1. The C‚O absorption band
appeared at 1680 cm1. Bands at 1595 and 1521 cm1 related
to the C‚C absorption further conﬁrm the structure of com-
pound. The 1H NMR of 1a showed a doublet signal at d 7.32
and d 7.63 due to furan protons, while the doublet signal at d
7.68 and d 7.79 related to phenyl protons, the singlet appeared
at d 9.62 is due to aldehyde proton.
The IR spectrum of imidazole compound 2a shows stretch-
ing absorption at 3437 cm1 related to N–H of imidazole ring,
bands at 3053 cm1 due to stretching of aromatic C–H. Theabsorption band of stretching C‚N appeared at 1681 cm1,
while bands at 1599 and 1489 cm1 were due to C‚C stretch-
ing. Fig. 1 shows the IR spectrum of compounds 2a–c. The 1H
NMR of compound 2a shows a multiplet signal at d 6.87–8.09
due to 16 aromatic protons and a singlet at d 13.00 related to
NH of imidazole ring further conﬁrming the structure. Fig. 2
depicts the 1H NMR of compounds 2a–c. The mass spectra
of the novel synthesized compounds 2a–c, showed a M+ 1
peak which satisﬁed their molecular formula. Spectral data,
physical properties and mass analysis of all the synthesized
compounds are given in the experimental section.
Table 1 Antimicrobial activity of imidazole derivatives represented by % inhibition against different microbial species.
Compound % Inhibition zone at 10 mg/mL against
Gram negative Gram positive Fungi
E. coli P. aeruginosa K. pneumoniae S. aureus Streptococcus SPP C. albicans
2a 133 0 122 0 72 66
2b 133 133 166 0 72 53
2c 111 111 155 0 72 60
Ampicillin 100 100 100 100 100 –
Fluconazole – – – – – 100
Note: the three derivatives 2a–c exhibit no activity against all microbial species at 1 mg/mL concentration.
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This research included the in vitro assay of the synthesized
compounds 2a–c against several microbial species (Table 1).
The in vitro assay achieved using two concentrations of syn-Figure 3 Ligplot of GlcN-6-P showing the binding of gthesized derivatives 1 and 10 mg/mL. At the lower concentra-
tion (1 mg/mL), the compounds were inactive against all
bacterial and fungi strains. The tested derivatives exhibited
promising activity at the 10 mg/mL concentration against
E. coli, P. aeruginosa, K. pneumonia (gram negative species)lucosamine-6-phosphate in an active site of enzyme.
S514 I.H.R. Tomi et al.and moderate activity against Streptococcus SPP (gram posi-
tive). When we compared the microbial activity of the com-
pounds with the standard drug, compound 2b shows highest
inhibition activity against K. pneumonia. All the tested com-
pounds showed no activity against S. aureus. The three deriv-
atives were screened against C. albicans, the common fungi
species and compound 2a evaluated as potent antifungal agent
with inhibition percent equal to 66%.
3.3. Molecular docking
The potent activity of synthesized compounds (2a–c) as new
antimicrobial agents, prompted us to study the docking of
these derivatives inside the active site of glucosamine-6-phos-
phate synthase, the potential target for antibacterial and anti-
fungal agents. X-ray study of glucosamine-6-phosphate
synthase with divergent inhibitors shows that the binding
pocket of the enzyme include the following residues, Cys
300, Gly 301, Thr 302, Ser 303, Ser 347, Gln 348, Ser 349,
Thr 352, Val 399, Ser 401, Ala 602 and Lys 603 as shown in
Fig. 3 which illustrates the in silico active pocket prediction
of amino acid residues in binding with glucosamine-6-phos-
phate enzyme obtained from PDB sum (Teplyakov et al.,
1998). Docking studies are computational techniques for theFigure 4 (a) 3D structure of GlcN-6-P synthase. (b) and (c) Bindin
respectively inside the binding pocket of GlcN-6-P synthase.exploration of the possible binding modes of a ligand to a gi-
ven receptor, enzyme or other binding site. In this study we
used autodock 4.2 to evaluate the binding energy of ligands in-
side the known 3D structure of target enzyme. AutoDock 4.2
software consists of two main programs, autogrid that pre-cal-
culates grid maps of interaction energies for various atom
types of ligand with a macromolecule and autodock, which
performs the docking of the ligand to speciﬁed grids (Morris
et al., 1996). For the typical systems, docking is carried out
using a Lamarckian Genetic Algorithm (LGA), it is run several
times to give several docked conformations (ten conformers by
default) ranking according to their binding and intermolecular
energies. Several parameters were also predicted by the auto-
dock program such as inhibition constant, number of hydro-
gen bonds and others. Fig. 4 illustrates the binding of the
best generated conformers for compounds 2a–c inside the
binding pocket of target enzyme. Table 2 indicates the molec-
ular docking parameters of compounds 2a–c. The high ranking
binding energies of the generated conformer were 7.37, 7.62
and 7.61 kcal mol1 for 2a–c, respectively. The high docking
energies of all generated conformers of compound 2b are
strongly proportional to the antibacterial activities as shown
in Table 1. Inhibition constant Ki, intermolecular energy and
hydrogen bonds were also determined and depicted in Table 2.g of the high ranking generated conformers for compounds 2a–c,
Table 2 Molecular docking parameter of imidazole derivatives with Glucosamine-6-phosphate synthase.
Compounds Binding energy (kcal mol1) Inhibition constant (lM) Intermolecular energy (kcal mol1) H-bonds Bonding
2a 1 7.37 3.94 uM 8.57 0 –
2 7.34 4.18 uM 8.53 0 –
3 7.29 4.52 uM 8.49 0 –
4 7.29 4.53 uM 8.48 0 –
5 6.71 12.15 uM 7.9 1 1MOQ:A:ALA602:HN: LIGAND:N
6 6.63 13.91 uM 7.82 1 1MOQ:A:ALA602:HN: LIGAND:N
7 6.63 13.87 uM 7.82 0 –
8 6.62 13.96 uM 7.82 0 –
9 6.6 14.45 uM 7.8 0 –
10 6.46 18.31 uM 7.66 0 –
2b 1 7.62 2.59 uM 8.52 1 1MOQ:A:GLY301:HN: LIGAND:O
2 7.61 2.66 uM 8.5 1 1MOQ:A:GLY301:HN: LIGAND:O
3 7.6 2.7 uM 8.49 1 1MOQ:A:GLY301:HN: LIGAND:O
4 7.59 2.75 uM 8.48 1 1MOQ:A:GLY301:HN: LIGAND:O
5 7.57 2.84 uM 8.46 1 1MOQ:A:GLY301:HN: LIGAND:O
6 7.54 2.97 uM 8.43 1 1MOQ:A:GLY301:HN: LIGAND:O
7 7.53 3.01 uM 8.43 1 1MOQ:A:GLY301:HN: LIGAND:O
8 7.53 3.01 uM 8.43 1 1MOQ:A:GLY301:HN: LIGAND:O
9 7.49 3.23 uM 8.39 1 1MOQ:A:GLY301:HN: LIGAND:O
10 7.48 3.3 uM 8.37 1 1MOQ:A:GLY301:HN: LIGAND:O
2c 1 7.61 2.65 uM 8.8 2 1MOQ:A:GLY301:HN: LIGAND:O
1MOQ:A:ASN305:HD22:LIGAND:O
2 7.54 2.96 uM 8.74 2 1MOQ:A:GLY301:HN: LIGAND:O
1MOQ:A:ASN305:HD22:LIGAND:O
3 7.48 3.31 uM 8.67 2 1MOQ:A:GLY301:HN: LIGAND:O
1MOQ:A:ASN305:HD22:LIGAND:O
4 7.04 6.92 uM 8.23 3 1MOQ:A:GLN348:HE21:LIGAND:O
1MOQ:A:SER349:HN: LIGAND:N
1MOQ:A:ALA602:HN2: LIGAND:O
5 7.01 7.24 uM 8.21 3 1MOQ:A:GLN348:HE21:LIGAND:O
1MOQ:A:SER349:HN: LIGAND:N 1MOQ:A:ALA602:HN2:
LIGAND:O
6 6.99 7.47 uM 8.19 2 1MOQ:A:GLN348:HE21:LIGAND:O
1MOQ:A:SER349:HN: LIGAND:O
7 6.82 9.97 uM 8.02 1 1MOQ:A:LYS603:HZ3: LIGAND:O
8 6.79 10.52 uM 7.98 1 1MOQ:A:LYS603:HZ3: LIGAND:O
9 6.75 11.35 uM 7.94 2 1MOQ:A:SER401:HG: LIGAND:O
1MOQ:A:LYS603:HZ3: LIGAND:O
10 6.64 13.61 uM 7.83 1 1MOQ:A:LYS603:HZ3: LIGAND:O
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S516 I.H.R. Tomi et al.The docking study reveals that the high afﬁnity of synthesized
derivatives (2a–c) within the binding pocket of glucosamine-6-
phosphate synthase strongly enhanced the determined activi-
ties of these derivatives as potent antimicrobial agents.
4. Conclusions
New derivatives of 2-[5-(4-substituted phenyl)furan-2-yl]-4,5-
diphenyl-1H-imidazole were synthesized and characterized
using IR, 1H NMR and GC–MS spectroscopy method. The
antimicrobial study of these derivatives against some gram po-
sitive and gram negative species as well as against C. albicans
was studied using the well diffusion method. The novel deriv-
atives were identiﬁed as promising antimicrobial agents. To ex-
plain the activity of new derivatives, we explore the binding
afﬁnity of the compounds against glucosamine-6-phosphate
synthase, the target enzyme for the antimicrobial agents.
Docking study strongly enhanced the activity of these com-
pounds as new discovered hits.Acknowledgment
This study was supported by the Chemistry Department,
College of Science, Al-Mustansiriyah University, Baghdad,
Iraq.
References
Barta, T.E., Stealey, M.A., Collins, P.W., Weier, R.M., 1998.
Antiinﬂammatory 4,5-diarylimidazoles as selective cyclooxygenase
inhibitors. Bioorg. Med. Chem. Lett. 8, 3443–3448.
Bearne, S.L., Blouin, C., 2000. Inhibition of Escherichia coli glucosa-
mine-6-phosphate synthase by reactive intermediate analogues. J.
Biol. Chem. 275 (1), 135–140.
Hussain, T., Siddiqui, H.L., Zia-ur-Rehman, M., Yasinzai, M.M.,
Parvez, M., 2009. Anti-oxidant, anti-fungal and anti-leishmanial
activities of novel 3-[4-(1H-imidazol-1-yl)phenyl]prop-2-en-1-ones.
Eur. J. Med. Chem. 44, 4654–4660.Kathiravan, M.K., Salake, A.B., Chothe, A.S., Dudhe, P.B., Watode,
R.P., Mukta, M.S., Gadhwe, S., 2012. The biology and chemistry
of antifungal agents: a review. Bioorg. Med. Chem. 20, 5678–5698.
Morris, G.M., Goodsell, D.S., Olson, J. 1996. AutoDock 2.4 User
Guide.
Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E.,
Belew, K.R., Olson, A.J., 1998. Automated docking using a
Lamarckian genetic algorithm and an empirical binding free energy
function. J. Comput. Chem. 19 (1), 639–1662.
Nagalakshmi, G., 2008. Synthesis and pharmacological evaluation of
2-(4-halosubstituted phenyl)-4,5-diphenyl-1H-imidazoles. Eur. J.
Chem. 5 (3), 447–452.
None, 2012. The Evolving Threat of Antimicrobial Resistance:
Options for Action. World Health Org..
Puterova´, Z., Sterk, H., Krutosˇı´kova´, A., 2004. Reaction of substituted
furan-2-carboxaldehydes and furo[b]pyrrole type aldehydes with
hippuric acid. Molecules 2004 (9), 11–21.
Refaat, H.M., 2010. Synthesis and anticancer activity of some novel 2-
substituted benzimidazole derivatives. Eur. J. Med. Chem. 45,
2949–2956.
Shingalapur, R.V., Hosamani, K.M., Keri, R.S., 2009. Synthesis and
evaluation of in vitro anti-microbial and anti-tubercular activity of
2-styryl benzimidazoles. Eur. J. Med. Chem. 44, 4244–4248.
Teplyakov, A., Obmolova, G., Badet-Denisot, M-A., Badet, B.,
Polikarpov, I., 1998. Involvement of the C terminus in intramo-
lecular nitrogen channeling in glucosamine 6-phosphate synthase:
evidence from a 16 A˚ crystal structure of the isomerase domain.
Structure 6 (8), 1047–1055.
Tomi, I.H.R., Al-Daraji, A.H.R., Al-Qaysi, R.R.T., Hasson, M.M.,
Al-Dulaimy, K.H.D., 2010. Synthesis, characterization and bio-
logical activities of some azo derivatives of aminothiadiazole
derived from nicotinic and isonicotinic acids. Arab. J. Chem..
http://dx.doi.org/10.1016/j.arabjc.2010.12.003.in press.
Tonelli, M., Simone, M., Tasso, B., Novelli, F., Boido, V., Sparatore,
F., Paglietti, G., Pricl, S., Giliberti, G., Blois, S., Ibba, C., Sanna,
G., Loddo, R., Colla, P.L., 2010. Antiviral activity of benzimid-
azole derivatives. II. Antiviral activity of 2-phenylbenzimidazole
derivatives. Bioorg. Med. Chem. 18, 2937–2953.
Wentland, M.P., Bailey, D.M., Alexander, E.J., Castaldi, M.J.,
Ferrari, R.A., Haubrich, D.R., Luttinger, D.A., Perrone, M.H.,
1987. Synthesis and antidepressant properties of novel 2-substi-
tuted 4,5-dihydro-1H-imidazole derivatives. J. Med. Chem. 30 (8),
1482–1489.
